Skip to content

A Study on Holo Arthritis Tablets to Help Reduce Knee and Joint Pain in Osteoarthritis Patients

A Clinical Study of Holo Arthritis in the Management of Sandhigata Vata (0steoarthritis) - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091417
Enrollment
60
Registered
2025-07-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M150- Primary generalized (osteo)arthritis

Interventions

None listed

Sponsors

Zeroharm Sciences Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having classical symptoms of Sandhigatavata (OA). 2.Having atleast one Radiological cardinal features like osteophytes or joint space narrowing.

Exclusion criteria

Exclusion criteria: Patient suffering from Gouty Arthritis, Generalized anasarca, Serious systemic illness, Metabolic syndrome etc.

Design outcomes

Primary

MeasureTime frame
Decrease in the classical symptoms of Sandhigatavata(Osteoarthritis)Timepoint: 3 MONTHS

Secondary

MeasureTime frame
Decrease in the classical symptoms of Sandhigatavata(Osteoarthritis) with improvement in radiological findingsTimepoint: 3 MONTHS

Countries

India

Contacts

Public ContactDr Shyamanta Kalita

Govt Ayurvedic College & Hospital

kalitashyamanta108@gmail.com7578890010

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026